Sherbrooke, Canada Clinical Trials
A listing of Sherbrooke, Canada clinical trials actively recruiting patients volunteers.
A Study of Pembrolizumab Added to the Standard First-Line Therapy of Cyclophosphamide Bortezomib and Dexamethasone (CyBorD) for NDMM NTE
This is a phase 2A multi-centre, open label, pilot study of pembrolizumab added to the standard first-line therapy of cyclophosphamide, bortezomib and dexamethasone (CyBorD) in newly diagnosed patients with multiple myeloma that are not eligible for autologous stem cell transplantation.
- 0 views
- 25 Jul, 2021
- +3 other locations